These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative cardiovascular effects of different progestins in menopause. Rosano GM, Fini M. Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [Abstract] [Full Text] [Related]
3. [Coronary disease in women]. García-Palmieri MR, Perea-López RM. P R Health Sci J; 1996 Dec; 15(4):283-8. PubMed ID: 9190622 [Abstract] [Full Text] [Related]
6. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter. Chew S, Ng SC. Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777 [Abstract] [Full Text] [Related]
7. [Hormone replacement therapy of menopause, heart and blood vessels]. Kuttenn F, Gerson M. Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629 [Abstract] [Full Text] [Related]
11. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene. Wenger NK, Geiger MJ. Contemp Clin Trials; 2005 Dec; 26(6):612-5. PubMed ID: 16257585 [Abstract] [Full Text] [Related]
12. Menopause and the risk of coronary heart disease in women. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. N Engl J Med; 1987 Apr 30; 316(18):1105-10. PubMed ID: 3574358 [Abstract] [Full Text] [Related]
13. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease. Windler E, Zyriax BC, Eidenmüller B, Boeing H. Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571 [Abstract] [Full Text] [Related]
14. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective. Mobasseri S, Liebson PR, Klein LW. Cardiol Rev; 2004 Jul 20; 12(6):287-98. PubMed ID: 15476565 [Abstract] [Full Text] [Related]
15. [Hormone replacement therapy of menopause in women with vascular risk factors]. Charbonnel B. Diabete Metab; 1993 Jul 20; 19(4):387-90. PubMed ID: 8293865 [No Abstract] [Full Text] [Related]
16. Statement on results of the HERS II trial on hormone replacement therapy. American College of Obstetricians and Gynecologists. Ginecol Obstet Mex; 2002 Aug 20; 70():406-8. PubMed ID: 12448046 [No Abstract] [Full Text] [Related]
17. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate. Hulley S. Can J Cardiol; 2000 Aug 20; 16 Suppl E():10E-12E. PubMed ID: 10906618 [Abstract] [Full Text] [Related]
18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J. Exp Clin Endocrinol Diabetes; 2005 Oct 20; 113(9):529-33. PubMed ID: 16235155 [Abstract] [Full Text] [Related]